Siv Jonsson (Siv Jönsson)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Monoclonal Antibody

Top Venues

CPT: pharmacometrics & systems pharmacology

Thrombosis and haemostasis

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Sánchez, Christina Claus, Rosmarie Albrecht, Brenda C Gaillard, Joana Marinho, Christine McIntyre, Tamara Tanos, Axel Boehnke, Lena E Friberg, Siv Jonsson, Nicolas Frances
A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncology. CPT: pharmacometrics & systems pharmacology (2023)
Han Liu, Ana-Marija Milenković-Grišić, Sreenath M Krishnan, Siv Jonsson, Lena E Friberg, Pascal Girard, Karthik Venkatakrishnan, Yulia Vugmeyster, Akash Khandelwal, Mats O Karlson
A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Laura H Bukkems, Siv Jonsson, Marjon H Cnossen, Mats O Karlson, Ron A A Mathôt, null null
Relationship between factor VIII levels and bleeding for rFVIII-SingleChain in severe hemophilia A: A repeated time-to-event analysis. CPT: pharmacometrics & systems pharmacology (2023)
Ana-Marija Grisic, Wenyuan Xiong, Lénaïg Tanneau, Siv Jonsson, Lena E Friberg, Mats O Karlsson, Haiqing Dai, Jenny Zheng, Pascal Girard, Akash Khandelwal
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Laura H Bukkems, Olav Versloot, M Cnossen, Siv Jonsson, Mats Karlsson, Ron A Mathôt, Kathelijn Fischer
Association between sports participation, factor VIII levels and bleeding in hemophilia A. Thrombosis and haemostasis (2022)
Anita Moein, Tong Lu, Siv Jonsson, Jakob Ribbing, Nastya Kassir, Wenhui Zhang, Gizette Sperinde, Rong Zhang, Meina T Tang, Young S Oh, René Bruno, Rui Zhu
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis. CPT: pharmacometrics & systems pharmacology 11 (9) (2022)
Iris K Minichmayr, Mats O Karlsson, Siv Jonsson
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety. Pharmaceutical research 38 (4) (2021)
Chao Chen, Siv Jonsson, Shuying Yang, Elodie L Plan, Mats O Karlson
Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item-score models. CPT: pharmacometrics & systems pharmacology 10 (4) (2021)
Maria Swartling, Anna-Karin Smekal, Mia Furebring, Miklos Lipcsey, Siv Jonsson, Elisabet I Nielsen
Population pharmacokinetics of cefotaxime in intensive care patients. European journal of clinical pharmacology (2021)
Ari Brekkan, Johanna Degerman, Siv Jonsson
Model-based evaluation of low-dose factor VIII prophylaxis in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
João A Abrantes, Siv Jonsson, Mats O Karlsson, Elisabet I Nielsen
Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data. British journal of clinical pharmacology 85 (6) (2019)